Unaudited Condensed Consolidated Interim Financial Statements for the six months ended 31 December 2020 ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced”) ISIN Code: ZAE000189049 JSE Code: AVL UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2020 HIGHLIGHTS - Revenue increased by 30% to R340.1 million (2019: R261.8 million). - EBITDA improved by 84% to R71.9 million (2019: R39.0 million). - Loss of R5.6 million (2019: loss of R20.0 million) from continuing operations was reduced by 72%. - Cash generated from operations increased by 67% to R73.1 million (2019: R43.9 million). - Basic loss per share from both continuing and discontinued operations decreased to 2.90 cents (2019: basic loss per share of 7.47 cents). - Headline loss per share decreased to 2.16 cents (2019: headline loss per share of 6.92 cents). No dividend is proposed or recommended for the six-month period ended 31 December 2020. Short-form announcement The contents of the short-form announcement are the responsibility of the Board of Directors of Advanced Health Limited. The information in the short-form announcement is a summary of the full announcement and accordingly does not contain full or complete details. The full announcement is available for inspection at no charge, Monday to Friday, during office hours at the company’s registered office, the office of the Designated Advisor and on the Company’s website on http://www.advancedhealth.co.za/ from 26 February 2021. The full announcement is available on SENS from 26 February 2021 at https://senspdf.jse.co.za/documents/2021/jse/isse/AVL/DEC2020AVL.pdf. The information in this announcement has been extracted from the unaudited condensed consolidated interim financial statements for the six months ended 31 December 2020 and the short-form announcement itself has not been reviewed by the Company’s auditors. Any investment decisions by shareholders/investors should be based on the full announcement released to the JSE and published on the Company’s website. CORPORATE INFORMATION Advanced Health Limited Registered Address: (Incorporated in the Republic of South Africa) Building 3, Walker Creek Office Park Registration number: 2013/059246/06 90 Florence Ribeiro Avenue ISIN: ZAE000189049 JSE Code: AVL Muckleneuk 0002 Postnet Suite 668, Private Bag X1 The Willows, 0041 Executive directors Non-Executive Directors GJ van Emmenis (Chief Executive Officer) FA van Hoogstraten (Lead Independent) S Chonco (Chief Financial Officer) CA Grillenberger (Chairman) MC Resnik# (Chief Operational Officer Australia) PJ Jaffe# D Goss-Ross (Chief Operational Officer South Africa) CJPG van Zyl Dr WT Mthembu Dr J Oelofse YJ Visser Dr KE Legodi # Australian Company Secretary: M Janse van Rensburg Auditors: Mazars Transfer Secretaries: Link Market Services Proprietary Limited Date of announcement: 26 February 2021 Designated Advisor Grindrod Bank Limited Date: 26-02-2021 11:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.